Region |
Cancer Type |
Cases n(%) |
Controls n(%) |
Odd Ratio (95% CI) Pro/Pro vs. Arg/Arg |
Author |
China |
Nasopharyngeal Carcinoma |
64 |
99 |
2.00 (0.86-4.67) |
Golovleva et al. [17] |
Canada |
Head & Neck Cancer |
163 |
163 |
1.08 (0.36-3.20) |
Hamel et al. [18] |
India |
Oral Squamous Cell Carcinoma |
110 |
26 |
4.40 (0.90-21.56) |
Nagpal et al. [19] |
Thailand |
Nasopharyngeal Cancer |
102 |
148 |
1.93 (0.94-3.98) |
Tiwawech et al. [20] |
Brazil |
Head & Neck Cancer |
50 |
142 |
3.27 (0.90-11.87) |
Cortezzi et al. [21] |
Taiwan |
Hypopharyngeal Carcinoma |
53 |
53 |
3.67 (1.16-11.56) |
Twu et al. [22] |
Portugal |
Nasopharyngeal Carcinoma |
107 |
285 |
2.62 (1.10-6.30) |
Sousa et al. [23] |
Present Study |
Epithelial Ovarian Cancer |
100 |
100 |
5.3 (1.9-14.7) |
2013 |
|